000			02025nam a22002417i 4500
999			_c2145 _d2145
005			20200929111607.0
008			100913s1998 enk||||| |||| 00| 0 eng d
020			_a0412819007 (pbk.)
040			_aEG-NcFUE _erda
082	0	4	_221 _a615.3137 _bB.A.C
100	1		_aBayer, Antony. _98803 _eauthor.
245	1	0	_aClinicians' guide to Aspirin / _cAntony Bayer.
264		1	_aLondon : _bChapman and Hall Medical, _c1998.
300			_avii, 174 pages, [8] pages of plates : _billustrations (chiefly color), portrait ; _c25 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505			_aHistorical background -- Early history -- Reverend Mr. Edward Stone -- 19th century -- Felix Hoffmann and the Bayer Company -- Antithrombotic effects and prevention of vascular events -- Mechanism of action -- Pharmacokinetics and pharmaceutical considerations -- Physicochemical properties -- Pharmacokinetics -- Which preparation? -- Mode of action and pharmacological effects -- Mode of action -- Therapeutic use for inflammation, pain and fever -- Inflammation -- Pain -- Fever -- Therapeutic use in vascular diseases -- Primary prevention of occlusive cardiovascular disease -- Secondary prevention of occlusive cardiovascular disease -- Maintenance of vascular grafts and arterial patency -- What dose? -- Miscellaneous therapeutic uses -- Prevention of colorectal cancer -- Prevention of other cancers -- Prevention of cataract -- Pregnancy -- Prevention of cognitive decline and dementia -- Other possible therapeutic uses -- Adverse effects and toxicity -- Gastrointestinal side effects -- Intracranial bleeding -- Hypersensitivity -- Reye's syndrome -- Other adverse effects -- Toxicity -- Contraindications and drug interactions -- Contraindications and precautions -- Use in particular patient groups -- Interactions with other drugs.
650		0	_aAspirin.
942			_2ddc _cBK